125 related articles for article (PubMed ID: 27267712)
1. Effects of Intracerebroventricular Administration of Neuropeptide Y on Metabolic Gene Expression and Energy Metabolism in Male Rats.
Su Y; Foppen E; Fliers E; Kalsbeek A
Endocrinology; 2016 Aug; 157(8):3070-85. PubMed ID: 27267712
[TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricular neuropeptide Y acutely influences glucose metabolism and insulin sensitivity in the rat.
Marks JL; Waite K
J Neuroendocrinol; 1997 Feb; 9(2):99-103. PubMed ID: 9041362
[TBL] [Abstract][Full Text] [Related]
3. Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways.
Baran K; Preston E; Wilks D; Cooney GJ; Kraegen EW; Sainsbury A
Diabetes; 2002 Jan; 51(1):152-8. PubMed ID: 11756335
[TBL] [Abstract][Full Text] [Related]
4. Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats.
Sainsbury A; Cusin I; Rohner-Jeanrenaud F; Jeanrenaud B
Diabetes; 1997 Feb; 46(2):209-14. PubMed ID: 9000696
[TBL] [Abstract][Full Text] [Related]
5. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity.
Zarjevski N; Cusin I; Vettor R; Rohner-Jeanrenaud F; Jeanrenaud B
Endocrinology; 1993 Oct; 133(4):1753-8. PubMed ID: 8404618
[TBL] [Abstract][Full Text] [Related]
6. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism.
Billington CJ; Briggs JE; Grace M; Levine AS
Am J Physiol; 1991 Feb; 260(2 Pt 2):R321-7. PubMed ID: 1996719
[TBL] [Abstract][Full Text] [Related]
7. Central neuropeptide Y infusion and melanocortin 4 receptor antagonism inhibit thyrotropic function by divergent pathways.
Preston E; Cooney GJ; Wilks D; Baran K; Zhang L; Kraegen EW; Sainsbury A
Neuropeptides; 2011 Dec; 45(6):407-15. PubMed ID: 21862125
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism.
Billington CJ; Briggs JE; Harker S; Grace M; Levine AS
Am J Physiol; 1994 Jun; 266(6 Pt 2):R1765-70. PubMed ID: 8024026
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and orexigenic effects of intracerebroventricular neuropeptide Y are attenuated by food deprivation.
Parikh R; Marks JL
J Neuroendocrinol; 1997 Oct; 9(10):789-95. PubMed ID: 9355048
[TBL] [Abstract][Full Text] [Related]
10. Activation of the NPY Y5 receptor regulates both feeding and energy expenditure.
Hwa JJ; Witten MB; Williams P; Ghibaudi L; Gao J; Salisbury BG; Mullins D; Hamud F; Strader CD; Parker EM
Am J Physiol; 1999 Nov; 277(5):R1428-34. PubMed ID: 10564216
[TBL] [Abstract][Full Text] [Related]
11. Some acute effects of intracerebroventricular neuropeptide Y on insulin secretion and glucose metabolism in the rat.
Marks JL; Waite K
J Neuroendocrinol; 1996 Jul; 8(7):507-13. PubMed ID: 8843019
[TBL] [Abstract][Full Text] [Related]
12. Selective dependence of intracerebroventricular neuropeptide Y-elicited effects on central glucocorticoids.
Zakrzewska KE; Sainsbury A; Cusin I; Rouru J; Jeanrenaud B; Rohner-Jeanrenaud F
Endocrinology; 1999 Jul; 140(7):3183-7. PubMed ID: 10385413
[TBL] [Abstract][Full Text] [Related]
13. Similar effects of NPY on energy metabolism and on plasma insulin in adrenalectomized ob/ob and lean mice.
Walker HC; Romsos DR
Am J Physiol; 1993 Feb; 264(2 Pt 1):E226-30. PubMed ID: 8447389
[TBL] [Abstract][Full Text] [Related]
14. Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats.
Pierroz DD; Catzeflis C; Aebi AC; Rivier JE; Aubert ML
Endocrinology; 1996 Jan; 137(1):3-12. PubMed ID: 8536627
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y in the noradrenergic neurones induces obesity and inhibits sympathetic tone in mice.
Vähätalo LH; Ruohonen ST; Mäkelä S; Kovalainen M; Huotari A; Mäkelä KA; Määttä JA; Miinalainen I; Gilsbach R; Hein L; Ailanen L; Mattila M; Eerola K; Röyttä M; Ruohonen S; Herzig KH; Savontaus E
Acta Physiol (Oxf); 2015 Apr; 213(4):902-19. PubMed ID: 25482272
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hypothalamic neuropeptide Y gene expression by insulin.
Schwartz MW; Sipols AJ; Marks JL; Sanacora G; White JD; Scheurink A; Kahn SE; Baskin DG; Woods SC; Figlewicz DP
Endocrinology; 1992 Jun; 130(6):3608-16. PubMed ID: 1597158
[TBL] [Abstract][Full Text] [Related]
17. Intracerebroventricular injection of neuropeptide Y modifies carbohydrate and lipid metabolism in chicks.
Tachibana T; Sato M; Oikawa D; Takahashi H; Boswell T; Furuse M
Regul Pept; 2006 Sep; 136(1-3):1-8. PubMed ID: 16713643
[TBL] [Abstract][Full Text] [Related]
18. Acute, subacute and chronic effects of central neuropeptide Y on energy balance in rats.
Székely M; Pétervári E; Pákai E; Hummel Z; Szelényi Z
Neuropeptides; 2005 Apr; 39(2):103-15. PubMed ID: 15752544
[TBL] [Abstract][Full Text] [Related]
19. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin.
Xu B; Dube MG; Kalra PS; Farmerie WG; Kaibara A; Moldawer LL; Martin D; Kalra SP
Endocrinology; 1998 Feb; 139(2):466-73. PubMed ID: 9449612
[TBL] [Abstract][Full Text] [Related]
20. Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue.
Sainsbury A; Cusin I; Doyle P; Rohner-Jeanrenaud F; Jeanrenaud B
Diabetologia; 1996 Mar; 39(3):353-6. PubMed ID: 8721783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
